Related StoriesPacemakers can detect AF and enable initiation of anticoagulation for stroke preventionMore study needed before recommending antidepressants, Alzheimer's disease medicines for stroke recovery: StudyMeta-analysis backs thrombectomy more than regular stroke careIn the current study, the research group obtained mortality and cause-of-death data for 100 % of the individuals through December of 2006. Using traditional along with novel statistical methods, the experts determined that the length in time that patients survived without encountering a cardiovascular-related death was significantly much longer for the group that received chlorthalidone treatment – around one day for every month of antihypertensive treatment. Because of the average age group of the trial group and the importance of competing factors behind death, such as cancer, in that group, the researchers analyzed in life expectancy for all-cause mortality also, which resulted in a gain of one-half day time for every month of antihypertensive treatment in the treatment group over the placebo group.NAFLD – the inappropriate storage space of extra fat droplets inside liver cells – may be the most common cause of chronic liver disease in the usa and affects nearly ten % of all children. Although kids with chronic liver disease often have no symptoms, some young children with NAFLD will have fatigue and/or abdominal pain. The original evaluation for NAFLD can be via a blood test and diagnosis is ultimately based on a liver biopsy. The disease is usually most common in kids and teenagers who are over weight and can develop together with other health complications, such as for example diabetes.